المؤلفون: Thomas Graier, MD, Wolfgang Weger, MD, Paul-Gunther Sator, MD, Wolfgang Salmhofer, MD, Barbara Gruber, MD, Constanze Jonak, MD, Claudia Kölli, MD, Martina Schütz-Bergmayr, MD, Igor Vujic, MD, Gudrun Ratzinger, MD, Nina Häring, MD, Clemens Painsi, MD, PhD, Knut Prillinger, MD, Alexander Mlynek, MD, Hans Skvara, MD, Hannes Trattner, MD, Adrian Tanew, MD, Roland Lichem, MD, Christina Ellersdorfer, MD, Franz Legat, MD, Alexandra Gruber-Wackernagel, MD, Angelika Hofer, MD, Erich Schmiedberger, MSc, Wolfram Hoetzenecker, MD, PhD, Robert Müllegger, MD, Werner Saxinger, MD, Franz Quehenberger, PhD, Peter Wolf, MD

المصدر: JAAD International, Vol 2, Iss , Pp 62-75 (2021)

مصطلحات موضوعية: apremilast, drug survival, psoriasis, Dermatology, RL1-803

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666328720300717; https://doaj.org/toc/2666-3287

URL الوصول: https://doaj.org/article/648c20cfa91b403eb35f5ba5638ed651